Yahoo Finance

Estimated Discount To Fair Value: 31.3%

Strides Pharma Science, trading at ₹1395.45, is 31.3% below its estimated fair value of ₹2032.1, indicating it is highly undervalued based on cash flows. The company’s revenue is forecast to grow at 11.5% annually, outpacing the Indian market's growth rate of 10.1%. Earnings are expected to increase by 98.07% per year and the company aims to become profitable within three years, reflecting strong potential for future profitability and value appreciation.

• In light of our recent growth report, it seems possible that Strides Pharma Science's financial performance will exceed current levels.

• Click to explore a detailed breakdown of our findings in Strides Pharma Science's balance sheet health report.

Titagarh Rail Systems

Overview: Titagarh Rail Systems Limited manufactures and sells freight and passenger rail systems in India and internationally, with a market cap of ₹180.87 billion.

Operations: The company's revenue segments include Passenger Rail Systems generating ₹3.32 billion and Freight Rail Systems (including Shipbuilding, Bridges, and Defence) contributing ₹35.14 billion.

Estimated Discount To Fair Value: 38.4%

Titagarh Rail Systems (₹1339.5) is trading at 38.4% below its estimated fair value of ₹2174.22, making it highly undervalued based on cash flows. The company’s earnings are forecast to grow 30.1% annually over the next three years, outpacing the Indian market's growth rate of 17.1%. Despite recent shareholder dilution, Titagarh's revenue is expected to increase by 25.7% per year, significantly faster than the market average of 10.1%.

• The analysis detailed in our Titagarh Rail Systems growth report hints at robust future financial performance.

• Unlock comprehensive insights into our analysis of Titagarh Rail Systems stock in this financial health report.

Seize The Opportunity

• Discover the full array of 27 Undervalued Indian Stocks Based On Cash Flows right here.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NSEI:JINDALSTEL NSEI:STAR and NSEI:TITAGARH.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com